Patents Assigned to DELPHI GENETICS
  • Patent number: 10718001
    Abstract: Disclosed is a host cell for producing a recombinant peptide, polypeptide or protein of interest, wherein the host cell includes at least 2 copies of a nucleic acid sequence encoding a poison protein; and to the use thereof for producing peptides, polypeptides or proteins of interest.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: July 21, 2020
    Assignee: DELPHI GENETICS
    Inventors: Cedric Szpirer, Jonathan Cavrenne, Benjamin Michel
  • Patent number: 9920323
    Abstract: The present invention relates to a genetically modified phage and use thereof in a method for producing a biomolecule of interest.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: March 20, 2018
    Assignee: DELPHI GENETICS
    Inventor: Cedric Szpirer
  • Publication number: 20140147890
    Abstract: The present invention relates to a genetically modified phage and use thereof in a method for producing a bio molecule of interest.
    Type: Application
    Filed: July 6, 2012
    Publication date: May 29, 2014
    Applicant: DELPHI GENETICS
    Inventor: Cedric Szpirer
  • Publication number: 20130011898
    Abstract: The present invention relates to a genetically modified phage and use thereof in a method for producing a biomolecule of interest.
    Type: Application
    Filed: July 7, 2011
    Publication date: January 10, 2013
    Applicant: DELPHI GENETICS
    Inventor: Cédric Szpirer